Stocklytics Platform
Asset logo for symbol PDSB
PDS Biotechnology
PDSB44
$1.39arrow_drop_down2.11%-$0.03
Penny Stock
Asset logo for symbol PDSB
PDSB44

$1.39

arrow_drop_down2.11%
query_stats

PDSB is not a dividend stock

Therefore Dividends subscore should not be taken into consideration

For certain stocks classified as non-dividend stocks, dividend-related data may not be available or applicable. Non-dividend stocks are those where the company does not regularly distribute dividends to its shareholders.

Why No Data?

Non-dividend stocks typically do not offer regular dividend payments. As a result, there might be no dividend-related information or history for such stocks within our database.

Understanding Non-Dividend Stocks

Non-dividend stocks are characterized by companies that reinvest their profits back into the business for expansion, research, development, or other strategic purposes rather than distributing dividends to shareholders.

What This Means for Investors

Investors in non-dividend stocks often focus on capital appreciation, anticipating the value of their shares to increase over time without relying on dividend income.

Stay Updated

While dividend information may not be available for these stocks, other critical financial metrics and analyses are accessible on Stocklytics to aid in informed investment decisions.

Stock Split History (PDSB)

DateSplitMultipleCumulative
Multiple
Mar 18, 20191:20x0.1x0.1

PDS Biotechnology (PDSB) Dividends & Splits

PDS Biotechnology Corp (PDSB) does not currently pay dividends. As a clinical-stage biotechnology company, they focus on developing immunotherapies for various types of cancers. Their primary goal is to bring innovative treatments to patients and improve their quality of life.
In terms of stock splits, PDS Biotechnology Corp (PDSB) has not announced any splits in recent years. The company's stock price has been relatively stable, and they have not felt the need for any split to make their shares more accessible to investors.
Since PDS Biotechnology Corp (PDSB) does not pay dividends, there is no dividend yield to calculate. However, investors can consider other factors such as the company's growth potential and financial performance when evaluating the investment worthiness of the stock.
As for the dividend payout ratio, it is not applicable to PDS Biotechnology Corp (PDSB) since they do not distribute dividends. The company reinvests its earnings into research and development to advance its immunotherapy pipeline.
The dividend ex-date is also irrelevant for PDS Biotechnology Corp (PDSB) considering that they do not provide dividends. Shareholders do not need to track such dates to receive dividend payments from the company.
Since there have been no splits in recent years, the split multiple for PDS Biotechnology Corp (PDSB) is not applicable. The company's stock has not been divided into multiple shares.
As mentioned earlier, PDS Biotechnology Corp (PDSB) does not pay dividends, so there is no dividend amount per share to report. Investors interested in this stock should focus on its overall growth potential rather than dividends.
Without any dividend payments, there is no dividend growth rate to calculate for PDS Biotechnology Corp (PDSB). Investors should consider other factors such as the company's clinical trial results and partnerships when assessing its growth prospects.
Since dividends are not part of their business model, PDS Biotechnology Corp (PDSB) does not have a dividend yield range. Investors should evaluate the stock based on other metrics like the company's financials, pipeline progress, and market potential.
Since PDS Biotechnology Corp (PDSB) does not pay dividends, there is no specific dividend payment date to mention. Investors should focus on the company's clinical trial milestones and regulatory updates for potential stock price catalysts.
Given that PDS Biotechnology Corp (PDSB) does not distribute dividends, the dividend payment frequency is not applicable. Investors in this company should track developments in their immunotherapy programs and partnerships.
add PDS Biotechnology to watchlist

Keep an eye on PDS Biotechnology

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

search
help

Does PDS Biotechnology (PDSB) stock pay dividends?

No, PDS Biotechnology (PDSB) does not pay dividends. This could indicate that the company is currently focusing on reinvesting its earnings into growth opportunities rather than distributing them as dividends.
help

When was the last PDS Biotechnology (PDSB) stock split?

PDS Biotechnology (PDSB) has undergone 1 total stock splits. The most recent split was a 1:20 split on 2019 Mar 18, leaving the company with 37.41M shares outstanding. Since the company's inception, the cumulative multiple from splits is 0.1, indicating the overall effect of all splits on the original share count.

Take Your Investments to a Whole New Level